Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
technetium-99m bicisate (2 trials)
xenon xe-133 (2 trials)
hx4 (1 trial)
rgd-k5 (2 trials)
cp-18 (1 trial)
Breast Neoplasms (Phase 1)
Carotid Stenosis (Phase 2)
Constriction, Pathologic (Phase 2)
Embolism (Phase 3)
Head and Neck Neoplasms (Phase 2)
Pulmonary Embolism (Phase 3)
Rectal Neoplasms (Phase 2)
Trials (6 total)
Trial APIs (5 total)